Explore more publications!

Press Releases

Southeast Asia's Most Undervalued Property Condo Market Offers 8%+ Yields
ESET Research: Chinese PlushDaemon group compromises network devices for adversary-in-the-middle attacks
ESET Research: Chinese PlushDaemon group compromises network devices for adversary-in-the-middle attacks
Visit by Youk Bunna, Permanent Secretary of State of the Cambodian Ministry of Civil Service, Under the S R Nathan Fellowship, 4 to 8 November 2025

Visit by Youk Bunna, Permanent Secretary of State of the Cambodian Ministry of Civil Service, Under the S R Nathan Fellowship, 4 to 8 November 2025

Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area
Chongqing's Dazu District in Southwest China to Host Young Scholars for Innovative Grotto Conservation
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
Ziperase Strengthens APAC Team for Growth in Southeast Asia
24/7 Market News- Kraig Labs’ Production Program Enters Critical Phase as Initial Spider Silk Deliveries Nears
Key Catalysts Emerge in Oncology, Synthetic Biology, and M&A Activity as Markets Open
Grab Pilots High-Accuracy GPS Positioning System to Improve Location and Navigation Accuracy of GrabMaps in Singapore
UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of AVT06, biosimilar to Eylea® (aflibercept)
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update
ACA Pharma Announces Major Expansion of RYANODEX® Territory Outside the United States
Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05
Vosyn, the human-centered AI company announces Global AI Priorities, Impact & Investment Roadshow Across Asia and the Middle East featuring localized impact reports to promote responsible AI adoption and access capital
ThinkCareBelieve: Week 41 of Trump's Golden America
Members exchange views on transparency and non-preferential rules of origin

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions